9.500USD-1.04%Mkt Cap: 89.43M USDP/E: —Last update: 2026-06-01
LeonaBio, Inc., clinical-stage biopharmaceutical company, engages in the development of novel therapeutics for high unmet medical needs, including treatment-resistant metastatic breast cancer and amyotrophic lateral scle…
Industry Peers
BiotechnologyIndicators:|
Key Statistics
Company
Market Cap89.43M USD
Enterprise Value23.57M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-105.61M USD
Revenue/Share—
Last Price9.500 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees19
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-0.56
EV/Revenue—
P/S—
P/B3.20
EPS (TTM)-24.09
EPS (Forward)—
52W Range
2.73059% of range14.21
52W High14.21 USD
52W Low2.730 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-380.03%
ROA-114.60%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-45.73M USD
CapEx (TTM)—
FCF Margin—
FCF Yield-18.89%
Net Debt-66.99M USD
Net Debt/EBITDA1.60
Balance Sheet
Debt/Equity0.03
Current Ratio10.38
Quick Ratio10.15
Book Value/Sh2.977 USD
Cash/Share7.205 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateSep 18, 2025
Analyst Consensus
Rating1.8 (Buy)
Target (Mean)18.00 USD
Target Range16.00 USD – 20.00 USD
# Analysts2
Ownership
Shares Out.9.39M
Float6.41M
Insiders4.46%
Institutions70.34%
Short Interest
Short Ratio1.6d
Short % Float0.84%
Short % Out.0.66%
Shares Short61.95K
Short (prev mo.)78.42K
Technical
SMA 509.650 (-1.6%)
SMA 2006.072 (+56.5%)
Beta—
S&P 52W Chg27.94%
Avg Vol (30d)39.47K
Avg Vol (10d)55.28K
Technical Indicators
RSI (14)48.4
MACD0.1607
MACD Signal0.2582
MACD Hist.-0.0975
BB Upper11.03 USD
BB Middle9.972 USD
BB Lower8.911 USD
BB Width21.28%
ATR (14)0.9512 USD
Vol Ratio (20d)0.18x